Contact
Select Language
Back to Product Details
REF: 99PW-RP-ADVANCED-REPAIR-IMMUNE
99 Purity Clinical Research Library

Advanced Repair & Immune

Recovery ResearchCAS BlendPurity ≥99.0%

Abstract & Overview

Advanced Repair & Immune supplies BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg) and LL-37 (5 mg) as four separately labelled lyophilized vials. The panel pairs two structural repair compounds with two innate immune signaling compounds, spanning a chain-length range from a three-residue tripeptide to a 37-residue cathelicidin — a thirteen-fold molecular weight spread that makes milligram-for-milligram comparison across the tray invalid. Strengths are set at 10 mg for three components rather than the 5 mg typical of entry panels. Supplied for Research Use Only.

Technical Specifications

Molecular FormulaBlend — no single formula applies; BPC-157 C62H98N16O22, TB-500 (Ac-LKKTETQ) C34H62N10O13, KPV C16H30N4O4, LL-37 C205H340N60O53
Molar MassBPC-157 1419.5 g/mol; TB-500 fragment 819.0 g/mol; KPV 342.4 g/mol; LL-37 4493.3 g/mol — a thirteen-fold spread across the tray
CAS Registry NumberBlend
Optimal Storage-20°C (Stable Long Term)
SequenceBPC-157 Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; TB-500 Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln; KPV Lys-Pro-Val; LL-37 37-residue cathelicidin

Lot HPLC Verification

HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)

High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.

HPLC Chromatography Assay Report
Reference Spectrum

Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.

HPLC Method Conditions
SystemAgilent 1260 Infinity II
ColumnC18 5µm (4.6x250mm)
Mobile Phase0.1% TFA in H2O/ACN
Flow Rate1.0 mL/min
DetectionUV @ 220 nm
Inj. Volume10.0 µL
PeakRetention TimeArea (mAU*s)Area %
1 (Impurity)2.1012.50.35%
2 (Advanced Repair & Immune)9.203562.499.65%
How to Read This Report: What Does This Graph Prove?
1. The Single High Peak

The tall spike at 9.20 minutes represents the active compound (Advanced Repair & Immune). A single clean, tall peak confirms high concentration.

2. Purity Level (≥99%)

The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.

3. Flat Baseline (No Contaminants)

A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.

Mechanism & Signaling

TB-500 corresponds to the actin-binding domain of thymosin beta-4 and its studied action is sequestration of monomeric actin, an interaction defined at the structural level. BPC-157 is a synthetic sequence derived from a gastric juice protein with no identified receptor; its literature is organised around nitric oxide and angiogenic readouts. KPV is the terminal tripeptide of alpha-melanocyte stimulating hormone and is investigated as an NF-kappa-B modulator, including in orally delivered nanoparticle formats. LL-37 is the mature cathelicidin peptide released from the human CAMP gene product, amphipathic and membrane-active, with signaling roles alongside its direct antimicrobial behaviour.

Primary Research Directions

1

Elevated 10 mg fills on BPC-157, TB-500 and KPV — double the 5 mg entry-panel convention — supporting replicate arms from a single lot

2

Structural repair and innate immune signaling supplied on one tray, letting a single laboratory run both halves without cross-lot variables

3

LL-37 supplied as the full 37-residue mature cathelicidin with a complete mass-map release, not a truncated fragment sold under the same name

4

Deliberate 5 mg LL-37 fill set on molar rather than milligram parity with the tripeptide KPV, documented on the label

5

Written disclosure that BPC-157 has no identified receptor and that TB-500 is the Ac-LKKTETQ fragment rather than full-length thymosin beta-4

FAQ
08

Frequently Asked Questions

Scientific analysis and technical answers regarding the compounds.

01.

What is the primary grade of these compounds?

All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.

02

Are these peptides intended for human consumption?

+

No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.

03

How does research show these peptides should be stored?

+

Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.

04

What is reconstitution and what solvent should be used?

+

Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.

05

What does the HPLC chromatogram represent?

+

The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.

06

Can these research compounds be combined in a single study?

+

Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.

07

Why is molar mass and molecular formula variance important?

+

Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.

08

What documentation is provided for regulatory compliance?

+

Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.

Scientific Citations

Sikiric, P., Seiwerth, S., Skrtic, A., et al. (2025). 'BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide.' Pharmaceuticals, 18(10), 1450. DOI: 10.3390/ph18101450 | PMID: 41155565

Bock-Marquette, I., Saxena, A., White, M. D., et al. (2004). 'Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.' Nature, 432(7016), 466-472. DOI: 10.1038/nature03000 | PMID: 15565145

Dürr, U. H., Sudheendra, U. S., & Ramamoorthy, A. (2006). 'LL-37, the only human member of the cathelicidin family of antimicrobial peptides.' Biochimica et Biophysica Acta, 1758(9), 1408-1425. DOI: 10.1016/j.bbamem.2006.03.030 | PMID: 16716248

Academic Disclaimer

All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.

9:41
99 Purity Logo

99 Purity Wholesale

Institutional Access

Welcome to the 99 Purity B2B Concierge. Please select a procurement module to begin your direct encrypted inquiry.